BMT Pharmacists Conference

FRIDAY – FEBRUARY 13

7:00 am
Registration 

8:30 am
Welcome and Overview 
Ashley Morris Engemann, PharmD, BCOP

8:45 am
American Society of Hematology (ASH) Meeting Updates
Helen Leather, BPharm

9:45 am
Fertility Preservation Options in Cancer Patients
Andrea Milbourne, MD

11:00 am
Umbilical Cord Blood Transplantation in Adults
E. J. Shpall, MD

12:00 noon
Lunch Break

1:45 pm
Plerixafor (AMD3100) Is Necessary for Adequate Mobilization in Autologous HSCT Patients – Point/Counterpoint
Kamakshi Rao, PharmD
Lauren Decloe, PharmD

2:45 pm
Best Pharmacist Abstracts Session

4:00 pm
Management of Non-CMV Viral Infections
Michael Boeckh, MD

5:00 pm
Infectious Diseases Society of America (IDSA) and Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Meeting Updates
Elizabeth Dodds-Ashley, PharmD

6:00 pm
Adjourn

SATURDAY – FEBRUARY 14

8:30 am
THE BURDEN OF BACTERIAL AND VIRAL INFECTIONS IN BMT
 ■ Epidemiology, Risk Factors, Spectrum of Pathogens, Emerging Resistance
    Kieren Marr, MD
 ■ Clinical Assessment of the Transplant Patient with Fever 
     Dimitrios Kontoyiannis, MD
 ■ Newer Antibacterials and Antivirals:  What Is Their Role in Prophylactic,
    Empiric, Preemptive and Targeted Strategies?
     Russell Lewis, PharmD

10:15 am
Radiation Injury Treatment Network
John Chute, MD

11:15 am
BMT Clinical Trials Network Protocol Updates
Mitchell Horwitz, MD

12:15 pm
Lunch Break
 
1:45 pm
Management of Iron Overload in HSCT Recipients
Casey Williams, PharmD

2:45 pm
Acute Graft versus Host Disease Update
Michael Westmoreland, PharmD

4:00 pm
SUPPORTIVE CARE
 ■ Glucocorticoid-Induced Osteoporosis
    Julianna Burzynski, PharmD
 ■ Antiviral Prophylaxis in HSCT Recipients 
     LeAnne Kennedy, PharmD
 ■ Use of Rituximab in Stem Cell Mobilization Regimens
    Donald Hutcherson, BPharm
 ■ Incorporation of Aprepitant into HSCT Conditioning Regimens
     Karen Fancher, PharmD

6:00 pm
Adjourn